annual operating profit:
-$395.28M+$65.28M(+14.17%)Summary
- As of today (June 17, 2025), IOVA annual operating income is -$395.28 million, with the most recent change of +$65.28 million (+14.17%) on December 31, 2024.
- During the last 3 years, IOVA annual operating profit has fallen by -$52.58 million (-15.34%).
- IOVA annual operating profit is now -2501659.49% below its all-time high of -$15.80 thousand, reached on December 31, 2009.
Performance
IOVA Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$121.22M-$34.65M(-40.02%)Summary
- As of today (June 17, 2025), IOVA quarterly operating income is -$121.22 million, with the most recent change of -$34.65 million (-40.02%) on March 31, 2025.
- Over the past year, IOVA quarterly operating profit has dropped by -$3.50 million (-2.97%).
- IOVA quarterly operating profit is now -5270378.26% below its all-time high of -$2300.00, reached on December 31, 2009.
Performance
IOVA quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$398.78M-$3.50M(-0.89%)Summary
- As of today (June 17, 2025), IOVA TTM operating income is -$398.78 million, with the most recent change of -$3.50 million (-0.89%) on March 31, 2025.
- Over the past year, IOVA TTM operating profit has increased by +$68.65 million (+14.69%).
- IOVA TTM operating profit is now -2539887.26% below its all-time high of -$15.70 thousand, reached on December 31, 2009.
Performance
IOVA TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
IOVA Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.2% | -3.0% | +14.7% |
| 3 y3 years | -15.3% | -32.2% | -11.1% |
| 5 y5 years | -91.1% | -71.2% | -67.8% |
IOVA Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -15.3% | +14.2% | -40.0% | +0.0% | -11.1% | +14.7% |
| 5 y | 5-year | -91.1% | +14.2% | -105.6% | +0.0% | -67.8% | +14.7% |
| alltime | all time | <-9999.0% | +14.2% | <-9999.0% | +0.0% | <-9999.0% | +14.7% |
IOVA Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$121.22M(+40.0%) | -$398.78M(+0.9%) |
| Dec 2024 | -$395.28M(-14.2%) | -$86.58M(-2.8%) | -$395.28M(-8.1%) |
| Sep 2024 | - | -$89.07M(-12.6%) | -$429.96M(-6.4%) |
| Jun 2024 | - | -$101.91M(-13.4%) | -$459.25M(-1.7%) |
| Mar 2024 | - | -$117.72M(-2.9%) | -$467.43M(+1.5%) |
| Dec 2023 | -$460.56M(+15.5%) | -$121.26M(+2.4%) | -$460.56M(+3.2%) |
| Sep 2023 | - | -$118.36M(+7.5%) | -$446.34M(+4.2%) |
| Jun 2023 | - | -$110.09M(-0.7%) | -$428.37M(+2.5%) |
| Mar 2023 | - | -$110.86M(+3.6%) | -$418.02M(+4.8%) |
| Dec 2022 | -$398.88M(+16.4%) | -$107.04M(+6.6%) | -$398.88M(+1.9%) |
| Sep 2022 | - | -$100.39M(+0.7%) | -$391.31M(+3.8%) |
| Jun 2022 | - | -$99.73M(+8.7%) | -$377.15M(+5.1%) |
| Mar 2022 | - | -$91.71M(-7.8%) | -$358.85M(+4.7%) |
| Dec 2021 | -$342.70M(+30.8%) | -$99.47M(+15.3%) | -$342.70M(+9.9%) |
| Sep 2021 | - | -$86.24M(+5.9%) | -$311.77M(+9.6%) |
| Jun 2021 | - | -$81.43M(+7.7%) | -$284.50M(+6.7%) |
| Mar 2021 | - | -$75.57M(+10.3%) | -$266.70M(+1.8%) |
| Dec 2020 | -$261.94M(+26.6%) | -$68.53M(+16.2%) | -$261.94M(+1.3%) |
| Sep 2020 | - | -$58.97M(-7.3%) | -$258.51M(+2.9%) |
| Jun 2020 | - | -$63.63M(-10.1%) | -$251.16M(+5.7%) |
| Mar 2020 | - | -$70.81M(+8.8%) | -$237.70M(+14.9%) |
| Dec 2019 | -$206.87M(+61.3%) | -$65.11M(+26.2%) | -$206.87M(+17.1%) |
| Sep 2019 | - | -$51.61M(+2.9%) | -$176.71M(+10.3%) |
| Jun 2019 | - | -$50.16M(+25.5%) | -$160.15M(+13.3%) |
| Mar 2019 | - | -$39.99M(+14.4%) | -$141.37M(+10.2%) |
| Dec 2018 | -$128.26M(+38.1%) | -$34.94M(-0.3%) | -$128.26M(+7.4%) |
| Sep 2018 | - | -$35.06M(+11.7%) | -$119.39M(+11.9%) |
| Jun 2018 | - | -$31.38M(+16.7%) | -$106.67M(+7.9%) |
| Mar 2018 | - | -$26.88M(+3.1%) | -$98.87M(+6.5%) |
| Dec 2017 | -$92.88M(+73.2%) | -$26.07M(+16.7%) | -$92.88M(+12.3%) |
| Sep 2017 | - | -$22.34M(-5.2%) | -$82.73M(+4.2%) |
| Jun 2017 | - | -$23.58M(+12.9%) | -$79.36M(+17.6%) |
| Mar 2017 | - | -$20.88M(+31.2%) | -$67.51M(+25.9%) |
| Dec 2016 | -$53.64M | -$15.92M(-16.1%) | -$53.64M(+16.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$18.98M(+61.8%) | -$46.20M(+32.5%) |
| Jun 2016 | - | -$11.73M(+67.3%) | -$34.86M(+17.9%) |
| Mar 2016 | - | -$7.01M(-17.3%) | -$29.57M(+6.1%) |
| Dec 2015 | -$27.86M(+131.4%) | -$8.48M(+10.9%) | -$27.86M(+14.9%) |
| Sep 2015 | - | -$7.64M(+18.7%) | -$24.25M(+24.9%) |
| Jun 2015 | - | -$6.44M(+21.6%) | -$19.41M(+28.7%) |
| Mar 2015 | - | -$5.30M(+8.8%) | -$15.08M(+25.2%) |
| Dec 2014 | -$12.04M(-46.8%) | -$4.87M(+73.7%) | -$12.04M(-35.5%) |
| Sep 2014 | - | -$2.80M(+32.8%) | -$18.67M(-26.1%) |
| Jun 2014 | - | -$2.11M(-6.6%) | -$25.28M(+4.5%) |
| Mar 2014 | - | -$2.26M(-80.3%) | -$24.20M(+6.9%) |
| Dec 2013 | -$22.64M(+178.4%) | -$11.50M(+22.2%) | -$22.64M(+76.0%) |
| Sep 2013 | - | -$9.41M(+814.1%) | -$12.87M(+153.0%) |
| Jun 2013 | - | -$1.03M(+46.0%) | -$5.08M(-10.8%) |
| Mar 2013 | - | -$704.90K(-59.1%) | -$5.70M(-29.9%) |
| Dec 2012 | -$8.13M(-61.4%) | -$1.72M(+5.8%) | -$8.13M(-22.1%) |
| Sep 2012 | - | -$1.63M(-1.1%) | -$10.43M(-28.6%) |
| Jun 2012 | - | -$1.65M(-47.5%) | -$14.62M(-37.9%) |
| Mar 2012 | - | -$3.14M(-22.1%) | -$23.54M(+11.8%) |
| Dec 2011 | -$21.06M(+2482.6%) | -$4.02M(-30.8%) | -$21.06M(+20.1%) |
| Sep 2011 | - | -$5.81M(-44.9%) | -$17.53M(+47.5%) |
| Jun 2011 | - | -$10.56M(+1504.3%) | -$11.88M(+745.1%) |
| Mar 2011 | - | -$658.30K(+32.7%) | -$1.41M(+72.4%) |
| Dec 2010 | -$815.40K(+5060.8%) | -$496.10K(+197.1%) | -$815.40K(+153.5%) |
| Sep 2010 | - | -$167.00K(+97.4%) | -$321.60K(+103.4%) |
| Jun 2010 | - | -$84.60K(+25.0%) | -$158.10K(+105.9%) |
| Mar 2010 | - | -$67.70K(+2843.5%) | -$76.80K(+389.2%) |
| Dec 2009 | -$15.80K(-72.3%) | -$2300.00(-34.3%) | -$15.70K(-43.3%) |
| Sep 2009 | - | -$3500.00(+6.1%) | -$27.70K(+3.7%) |
| Jun 2009 | - | -$3300.00(-50.0%) | -$26.70K(-30.5%) |
| Mar 2009 | - | -$6600.00(-53.8%) | -$38.40K(-32.7%) |
| Dec 2008 | -$57.10K | -$14.30K(+472.0%) | -$57.10K(+33.4%) |
| Sep 2008 | - | -$2500.00(-83.3%) | -$42.80K(+6.2%) |
| Jun 2008 | - | -$15.00K(-40.7%) | -$40.30K(+59.3%) |
| Mar 2008 | - | -$25.30K | -$25.30K |
FAQ
- What is Iovance Biotherapeutics annual operating income?
- What is the all time high annual operating profit for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics annual operating profit year-on-year change?
- What is Iovance Biotherapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly operating profit year-on-year change?
- What is Iovance Biotherapeutics TTM operating income?
- What is the all time high TTM operating profit for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics TTM operating profit year-on-year change?
What is Iovance Biotherapeutics annual operating income?
The current annual operating profit of IOVA is -$395.28M
What is the all time high annual operating profit for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual operating income is -$15.80K
What is Iovance Biotherapeutics annual operating profit year-on-year change?
Over the past year, IOVA annual operating income has changed by +$65.28M (+14.17%)
What is Iovance Biotherapeutics quarterly operating income?
The current quarterly operating profit of IOVA is -$121.22M
What is the all time high quarterly operating profit for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly operating income is -$2300.00
What is Iovance Biotherapeutics quarterly operating profit year-on-year change?
Over the past year, IOVA quarterly operating income has changed by -$3.50M (-2.97%)
What is Iovance Biotherapeutics TTM operating income?
The current TTM operating profit of IOVA is -$398.78M
What is the all time high TTM operating profit for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high TTM operating income is -$15.70K
What is Iovance Biotherapeutics TTM operating profit year-on-year change?
Over the past year, IOVA TTM operating income has changed by +$68.65M (+14.69%)